Bentley Systems Brings Infrastructure Digital Twins to NVIDIA Omniverse
12.4.2021 20:00:00 EEST | Business Wire | Press release
GTC21 – Bentley Systems, Incorporated (Nasdaq: BSY), the infrastructure engineering software company, today announced that it is developing applications using the NVIDIA Omniverse platform for photorealistic, real-time visualization and simulation of digital twins of massive-scale industrial and civil infrastructure projects.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210412005214/en/
Image courtesy of Houston Waterworks Team (a Joint Venture of Jacobs Engineering Group, Inc. and CDM Constructors, Inc.)
Bentley Systems has extended the Bentley iTwin platform to integrate with NVIDIA Omniverse to provide a graphics pipeline for AI-enhanced, real-time visualization, and simulation of infrastructure digital twins. This integration allows engineering-grade, millimeter-accurate digital content to be visualized with photorealistic lighting and environmental effects on multiple devices including web browsers, workstations, tablets, and virtual reality and augmented reality headsets from anywhere in the world.
Bentley iTwin is an open, scalable cloud platform that enables engineering firms and owner-operators to create, visualize, and analyze digital twins of infrastructure assets. Digital information managers use it to incorporate engineering data created by diverse design tools into a living digital twin and align it with reality data, IoT data, and other associated data without disrupting their current tools or processes.
Bentley Systems CEO Greg Bentley said, “Visualization and simulation underpin many of the use cases for infrastructure digital twins. The collaboration of Bentley iTwin and NVIDIA Omniverse is delivering real-time, immersive 3D/4D experiences that will enable true-to-reality, physics-based simulation of even the largest and most complex infrastructure assets. GPU-computing is transforming the world of engineering and construction and promises to unleash the potential of AI for simulation and advanced analytics in infrastructure digital twins.”
“Modern infrastructure are magnificent feats of engineering. NVIDIA and Bentley share a vision of physically based digital twins – so accurate and realistically simulated that they will revolutionize everything from infrastructure design to operations,” said Jensen Huang, founder and CEO of NVIDIA. “NVIDIA Omniverse was built precisely to realize this vision – to create shared virtual worlds that are simulated with physical and photo realism. We are delighted Bentley is developing applications for infrastructure digital twins on NVIDIA Omniverse.”
Unmatched High-Fidelity Infrastructure Visualization
The combination of the Bentley iTwin platform and NVIDIA Omniverse provides an unmatched, high-performance user experience at a scale that had previously not been possible.
The integration of the capabilities of the Bentley iTwin platform and NVIDIA Omniverse enables users to virtually explore massive industrial plants and offshore structures as if they are walking through the infrastructure in real time, for purposes such as wayfinding and safety route optimization.
“The industry is moving in a positive direction toward more automated and sophisticated tools that improve client outcomes,” said Donna DeMarco, plant information modeling, Jacobs. “Jacobs is proud to partner with Bentley in leveraging tools like iTwin linked with NVIDIA Omniverse to achieve strong results for our clients.”
Image and caption:
Houston Waterworks
Image courtesy of Houston Waterworks Team (a Joint Venture of Jacobs Engineering Group, Inc. and CDM Constructors, Inc.)
About NVIDIA Omniverse
NVIDIA Omniverse is an open platform for virtual collaboration and physically accurate simulation. Based on NVIDIA RTX technology, it leverages the Universal Scene Description (USD) common interchange format for real-time 3D visualization and simulation that was originally developed by Pixar to simplify entertainment industry workflows and is now being adopted in other industries including architecture, construction, and engineering, and digital factories.
About the Bentley iTwin Platform
The Bentley iTwin platform is an open, scalable cloud platform that enables project teams and owner-operators to create, visualize, and analyze digital twins of infrastructure assets. It enables digital information managers to incorporate engineering data created by diverse design tools into a living digital twin and align it with reality data, and other associated data with no disruption to their current tools or processes. Users are able to visualize and track changes including changes in real world conditions from IoT connected devices, such as sensors and drones. The Bentley iTwin platform facilitates actionable insights for decision makers across the organization and asset lifecycle. Users make better-informed decisions, anticipate and avoid issues before they arise, and react more quickly with confidence, resulting in cost savings, improved service availability, lower environmental impact, and improved safety. The Bentley iTwin platform is the foundation for applications ‘powered by iTwin’ and digital twin solutions created by Bentley and its strategic partners, digital integrators, system integrators, independent software vendors, and software developers.
About Bentley Systems
Bentley Systems (Nasdaq: BSY) is the infrastructure engineering software company. We provide innovative software to advance the world’s infrastructure – sustaining both the global economy and environment. Our industry-leading software solutions are used by professionals, and organizations of every size, for the design, construction, and operations of roads and bridges, rail and transit, water and wastewater, public works and utilities, buildings and campuses, and industrial facilities. Our offerings include MicroStation-based applications for modeling and simulation, ProjectWise for project delivery, AssetWise for asset and network performance, and the iTwin platform for infrastructure digital twins. Bentley Systems employs more than 4,000 colleagues and generates annualized revenues of more than $800 million in 172 countries. www.bentley.com
© 2021 Bentley Systems, Incorporated. Bentley, the Bentley logo, AssetWise, iTwin, MicroStation, and ProjectWise are either registered or unregistered trademarks or service marks of Bentley Systems, Incorporated or one of its direct or indirect wholly owned subsidiaries. All other brands and product names are trademarks of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210412005214/en/
Contact information
Press:
Christine Byrne
+1 203 805 0432
Christine.Byrne@bentley.com
Follow us on Twitter:
@BentleySystems
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom